Verra Therapeutics
Company Details
Status: Private
Employees: 1-10
Location:
New York 14882
Type:
sample
Technology:
sample
sample
sample
About: Verra Therapeutics is a privately held company near Ithaca NY, that was founded in 2017 with a mission of transforming the treatment of protease-driven diseases using an innovative small protein platform.
Verra is developing preclinical drug candidates for Chronic Bronchitis, Acute Lung Injury and Acute Kidney Injury by adapting nature’s highly evolved design for each target protease.
Dr. Christopher Prince brings decades of leadership experience to the team in managing technology companies through biotech and pharmaceutical development. Dr. Marcia Moss has a comprehensive background in drug discovery and development and is a thought leader on proteases as disease targets.
Verra’s goal is to create novel, selective and impactful drugs for patients with major unsolved medical illnesses.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Verra Therapeutics | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.